A UK nationwide prospective study of treatment change in MODY: genetic subtype and clinical characteristics predict optimal glycaemic control after discontinuing insulin and metformin

GCK-MODY in the US National Monogenic Diabetes Registry: frequently misdiagnosed and unnecessarily treated

(2016) David Carmody et al.   ACTA DIABETOLOGICA

Targeted next-generation sequencing reveals MODY in up to 6.5% of antibody-negative diabetes cases listed in the Norwegian Childhood Diabetes Registry

(2016) Bente B. Johansson et al.   DIABETOLOGIA

Recognition and Management of Individuals With Hyperglycemia Because of a Heterozygous Glucokinase Mutation

(2015) Ali J. Chakera et al.   DIABETES CARE

Adolescent non-adherence reveals a genetic cause for diabetes

(2015) D. Carmody et al.   DIABETIC MEDICINE

Successful maintenance on sulphonylurea therapy and low diabetes complication rates in a HNF1A-MODY cohort

(2015) S. Bacon et al.   DIABETIC MEDICINE

Prevalence of Vascular Complications Among Patients With Glucokinase Mutations and Prolonged, Mild Hyperglycemia

(2014) Anna M. Steele et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Identifying monogenic diabetes in a pediatric cohort with presumed type 1 diabetes

(2014) Rachelle G. Gandica et al.   PEDIATRIC DIABETES

The diagnosis and management of monogenic diabetes in children and adolescents

(2014) Oscar Rubio-Cabezas et al.   PEDIATRIC DIABETES

Cross-sectional and longitudinal studies suggest pharmacological treatment used in patients with glucokinase mutations does not alter glycaemia

(2013) Amanda Stride et al.   DIABETOLOGIA

Prevalence of monogenic diabetes in the population-based Norwegian Childhood Diabetes Registry

(2013) H. U. Irgens et al.   DIABETOLOGIA

Prevalence, Characteristics and Clinical Diagnosis of Maturity Onset Diabetes of the Young Due to Mutations in HNF1A, HNF4A, and Glucokinase: Results From the SEARCH for Diabetes in Youth

(2013) Catherine Pihoker et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

A case of hepatocyte nuclear factor-1β (TCF2) maturity onset diabetes of the young misdiagnosed as type 1 diabetes and treated unnecessarily with insulin (一例肝细胞核因子-1b (TCF2)突变的青年人中的成年发病型糖尿病（MODY）被误诊为1型糖尿病并且被不必要地使用胰岛素治疗)

(2013) Arthi Thirumalai et al.   Journal of Diabetes

Systematic Assessment of Etiology in Adults With a Clinical Diagnosis of Young-Onset Type 2 Diabetes Is a Successful Strategy for Identifying Maturity-Onset Diabetes of the Young

(2012) G. Thanabalasingham et al.   DIABETES CARE

Maturity-onset diabetes of the young (MODY): how many cases are we missing?

(2010) B. M. Shields et al.   DIABETOLOGIA

A genetic diagnosis ofHNF1Adiabetes alters treatment and improves glycaemic control in the majority of insulin-treated patients

(2009) M. Shepherd et al.   DIABETIC MEDICINE

Increased all-cause and cardiovascular mortality in monogenic diabetes as a result of mutations in the HNF1A gene

(2009) A. M. Steele et al.   DIABETIC MEDICINE

10-Year Follow-up of Intensive Glucose Control in Type 2 Diabetes

(2008) Rury R. Holman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clinical implications of a molecular genetic classification of monogenic β-cell diabetes

(2008) Rinki Murphy et al.   Nature clinical practice. Endocrinology & metabolism